2vqn
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | '''Unreleased structure''' | |
- | + | The entry 2vqn is ON HOLD | |
+ | |||
+ | Authors: Szegezdi, E., Mahalingam, D., van der Sloot, A.M., Cool, R., Munoz, I.G., Montoya, G., Serrano, L., Quax, W.J., de Jong, S., Samali, A. | ||
+ | |||
+ | Description: Selective activation of DR5 leads to enhanced apoptosis signalling in DR5-sensitive tumour cells | ||
+ | [[Category: Unreleased Structures]] | ||
+ | [[Category: Cool, R]] | ||
+ | [[Category: Mahalingam, D]] | ||
+ | [[Category: De Jong, S]] | ||
+ | [[Category: Quax, W.J]] | ||
+ | [[Category: Munoz, I.G]] | ||
+ | [[Category: Van Der Sloot, A.M]] | ||
+ | [[Category: Szegezdi, E]] | ||
+ | [[Category: Montoya, G]] | ||
+ | [[Category: Serrano, L]] | ||
+ | [[Category: Samali, A]] |
Revision as of 05:46, 24 June 2020
Unreleased structure
The entry 2vqn is ON HOLD
Authors: Szegezdi, E., Mahalingam, D., van der Sloot, A.M., Cool, R., Munoz, I.G., Montoya, G., Serrano, L., Quax, W.J., de Jong, S., Samali, A.
Description: Selective activation of DR5 leads to enhanced apoptosis signalling in DR5-sensitive tumour cells